In the main per-protocol analyses, participants were followed from the index date to first mutually exclusive incidence of SIS, discontinuation of study drug (defined as more than 60 days without drug supply), initiation of other study drug, or switch to other glucose-lowering drug (defined as filling a prescription for any glucose-lowering drug other than the baseline treatment or metformin and not refilling the assigned drug for 60 days), death, or end of follow-up
Tirzepatide with Glycine and B12 is a physician-prescribed, compounded injectable medication designed to promote significant, sustainable weight losswhile also supporting energy, metabolic function, and cellular recovery
By addressing both obesity linked obstructive sleep apnea and mechanical airway collapse, healthcare providers can create a comprehensive plan for each patient
Participants recorded a 12.4% average body weight loss
Berberine is a plant-based compound that supports metabolism, improves gut health, and has been shown in clinical studies to lead to modest but meaningful weight loss
Allow your body ample time at each dose level before adjusting upward
&srotate=0)
